Global tumor board maps investigational options for glioblastoma with MDM2 and EGFR amplifications
A new Oncotarget case report details how the WIN Consortium's international molecular tumor board evaluated investigational EGFR, MDM2, CDK4/6 and ...
Tag: molecular tumor board
POPULAR NEWS
-
Skin assay detects and types alpha-synuclein seeds in multiple system atrophy
-
New Shipborne Gravimetry Method Stays Accurate When GNSS Signals Fail
-
Global tumor board maps investigational options for glioblastoma with MDM2 and EGFR amplifications
-
Ion Channel Axis KCNE3-KCNQ1 Drives Bone Repair Through Vessel and Energy Metabolism Coupling